Skip to main content

Nifty forms Hanging Man pattern, 12,770 crucial for further upside

Mazhar Mohammad of Chartviewindia.in advised traders to remain neutral and wait for some signs of weakness before shorting.

The Nifty50 opened at record high levels and faced volatility during the day, but the rebound in the last couple of hours of trade helped the index to end at fresh record closing high on November 11.

Bulls continued their support for the eighth consecutive session and as a result, the index formed bullish candle which resembles a Hanging Man kind of pattern on the daily charts.

A Hanging Man is a bearish reversal candlestick pattern which is usually formed at the end of an uptrend or at the top (around 8.5 percent rally in 7-trading sessions). In a perfect 'Hanging Man' pattern either there will be a small upper shadow or no upper shadow at all, a small body and long lower shadow.

The consistent flow of FII money and buying in banking & financials, auto, FMCG, metals and pharma stocks pushed the market higher.



Experts feel the 12,770 would be crucial level to watch out for, if the index strongly surpasses the same then 12,850 can be possible on the Nifty in coming days.

As of now, except overbought readings on momentum oscillators, no other weak signs are visible on the charts, said Mazhar Mohammad of Chartviewindia.in. Hence, in the next trading session if bulls manage to push indices beyond 12,770 levels then the strength in Nifty shall get extended further towards 12,850 levels, he feels.

Therefore, he advised traders to remain neutral and wait for some signs of weakness before shorting.

The Nifty50 opened higher at 12,680.60 and witnessed some volatility during the day. The index touched an intraday high of 12,769.75 and low of 12,571.10, before signing off the session at 12,749.20, up 118.10 points.

"Albeit Nifty50 posted a strong show with smart recovery from intraday low of 12,572 levels, it registered a Hanging Man kind of formation on the candlestick charts which is usually found around potential turning points as trend nears exhaustion," Mazhar Mohammad, Chief Strategist – Technical Research & Trading Advisory at Chartviewindia.in told Moneycontrol.

Nevertheless, confirmation of weakness will occur if Nifty trades below 12,571 in next session which shall potentially trigger a short term downswing, he feels.

Moreover, based on long term trend analysis Nifty has critical resistance in the zone of 12750 – 12,800 levels, he said, adding this zone can be a potential turning point for the indices going forward.

India VIX increased further, up by 2.10 percent from 21.57 to 22.03 levels today.

Option data indicated that a wider trading range for the Nifty could be 12,400 to 13,000 levels.

On option front, maximum Put open interest was seen at 12,000 followed by 11,000 strike while maximum Call open interest was seen at 13,000 followed by 12,500 strike. Call writing was seen in 12,700 and 13,000 strike while Put writing was seen at 12,700 then 12,600 strike.

Bank Nifty opened positive at 28,713.15 and continued its upward movement to hit a day's high of 29,030.90. It managed to close the session with gains of 239 points at 28,845 in spite of consolidation in some banking stocks. It formed a small bodied candle on daily scale but has been making higher highs - higher lows from last eight trading sessions.

"Bank Nifty has to continue to hold above 28,200 to witness an upmove towards 29,250-29,500 levels," Chandan Taparia, Vice President | Analyst-Derivatives at Motilal Oswal Financial Services said.

Positive setup was seen in Hindalco, Tata Steel, Apollo Hospitals, IGL, SAIL, Jubilant Foodworks, Eicher Motors, Axis Bank, Tata Motors, ITC, UltraTech Cement, Escorts, JSW Steel and MGL while weakness was seen in Reliance Industries, Bata India, Muthoot Finance and Dabur, he added.

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Brokerages place bets on Titan, see double-digit upside in the stock

Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. After three consecutive sessions of losses, shares of Titan Company rose over a percent in morning trade on BSE on September 23. The company was dealt a severe blow by COVID-19 as the pandemic triggered strict lockdowns completely battered the retail sector. In the calendar year so far, shares of this one of the largest, most efficient and profitable specialty retailer in India are 7 percent down. The company reported a net standalone loss of Rs 270 crore for the quarter ended June 2020 as the COVID-19 pandemic hit business. The loss was higher than a CNBC-TV18 poll estimate of Rs 175 crore. Standalone revenue during the quarter declined 62.3 percent year-on-year to Rs 1,862 crore compared to the corresponding period last fiscal. Light at the end ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more